Complementation of Brucella abortus RB51 with a functional wboA gene results in O-antigen synthesis and enhanced vaccine efficacy but no change in rough phenotype and attenuation

Infection and Immunity

Volumn 68, Issue 7, 2000, Pages 3927-3932

  Vemulapalli, Ramesh ^a   He, Yongqun ^a   Buccolo, Larissa S ^a   Boyle, Stephen M ^a   Sriranganathan, Nammalwar ^a   Schurig, Gerhardt G ^a  

^a CENTER FOR MOLECULAR MEDICINE AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; GAMMA INTERFERON; POLYSACCHARIDE; VACCINE;

ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; BRUCELLA ABORTUS; CONTROLLED STUDY; GENE DISRUPTION; GENE FUNCTION; GENE MUTATION; GENETIC COMPLEMENTATION; IMMUNE RESPONSE; IMMUNIZATION; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE;

ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL VACCINES; BRUCELLA ABORTUS; FEMALE; GENES, BACTERIAL; GENETIC COMPLEMENTATION TEST; INTERFERON TYPE II; MICE; MICE, INBRED BALB C; MICROSCOPY, IMMUNOELECTRON; O ANTIGENS; PHENOTYPE; VIRULENCE;

EID: 0033944862     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.68.7.3927-3932.2000     Document Type: Article

References (37)

1. Allen, C. A., L. Garry Adams, and T. A. Ficht. 1998. Transposon-derived Brucella abortus rough mutants are attenuated and exhibit reduced intracellular survival. Infect. Immun. 66:1008-1016.
2. Alton, G. G., L. M. Jones, and D. E. Pietz. 1975. Laboratory techniques in Brucellosis. World Health Organization monograph series no. 55. World Health Organization, Geneva, Switzerland.
3. Araya, L. N., P. H. Elzer, G. E. Rowe, F. M. Enright, and A. J. Winter. 1989. Temporal development of protective cell-mediated and humoral immunity in BALB/c mice infected with Brucella abortus. J. Immunol. 143:3330-3337.
4. Araya, L. N., and A. J. Winter. 1990. Comparative protection of mice against virulent and attenuated strains of Brucella abortus by passive transfer of immune T cells or serum. Infect. Immun. 58:254-256.
5. Bundle, D. R., J. W. Cherwonogrodzky, and M. B. Perry. 1987. The structure of the lipopolysaccharide O-chain (M-antigen) and polysaccharide B produced by Brucella melitensis 16M. FEMS Microbiol. Lett. 216:261-264.
6. Caroff, M., D. R. Bundle, M. B. Perry, J. W. Cherwonogrodzky, and J. R. Duncan. 1984. Antigenic S-type lipopolysaccharide of Brucella abortus 1119-3. Infect. Immun. 46:384-389.
7. Cherwonogrodzky, J. W., G. Dubray, E. Moreno, and H. Mayer. 1990. Antigens of Brucella, p. 19-64. In K. Nielsen, and J. R. Duncan (ed.), Animal brucellosis. CRC Press, Inc., Boca Raton, Fla.
8. Cheville, N. F., M. G. Stevens, A. E. Jensen, F. M. Talum, and S. M. Halling. 1993. Immune responses and protection against infection and abortion in cattle experimentally vaccinated with mutant strains of Brucella abortus. Am. J. Vet. Res. 54:1591-1597.
9. Cloeckaert, A., M. S. Zygmunt, G. Dubray, and J. N. Limet. 1993. Characterization of O-polysaccharide specific monoclonal antibodies derived from mice infected with the rough Brucella melitensis strain B115. J. Gen. Microbiol. 139:1551-1556.
10. Cloeckaert, A., M. S. Zygmunt, J. C. Nicolle, G. Dubray, and J. N. Limet. 1992. O-chain expression in the rough Brucella melitensis strain B115: induction of O-polysaccharide-specific monoclonal antibodies and intracellular localization demonstrated by immunoelectron microscopy. J. Gen. Microbiol. 138:1211-1219.
11. Corbel, M. J. 1997. Brucellosis: an overview. Emerg. Infect. Dis. 3:213-221.
12. Eisenschenk, F. C., J. J. Houle, and E. M. Hoffmann. 1995. Serum sensitivity of field isolates and laboratory strains of Brucella abortus. Am. J. Vet. Res. 56:1592-1598.
13. Elzer, P. H., R. H. Jacobson, K. H. Nielsen, J. T. Douglas, and A. J. Winter. 1994. BALB/c mice infected with Brucella abortus express protracted polyclonal responses of both IgG2a and IgG3 isotypes. Immunol. Lett. 42:145-150.
14. Escola, J. M., E. Moreno, P. Chavrier, and J. P. Gorvel. 1994. The O-chain of Brucella abortus lipopolysaccharide induces SDS-resistant MHC II molecules in mouse B cells. Biochem. Biophys. Res. Commun. 203:1230-1236.
15. Forestier, C., E. Moreno, S. Meresse, A. Phalipon, D. Olive, P. Sansonetti, and J. P. Gorvel. 1999. Interaction of Brucella abortus lipopolysaccharide with major histocompatibility complex class II molecules in B lymphocytes. Infect. Immun. 67:4048-4054.
16. Forestier, C., E. Moreno, J. Pizarro-Cerola, and J. P. Gorvel. 1999. Lysosomal accumulation and recycling of lipopolysaccharide to the cell surface of murine macrophages, an in vitro and in vivo study. J. Immunol. 162:6789-6791.
17. Frenchick, P. J., R. J. F. Markham, and A. H. Cochrane. 1985. Inhibition of phagosome-lysosome fusion in macrophages by soluble extracts of virulent Brucella abortus. Am. J. Vet. Res. 46:332-335.
18. Godfroid, F., B. Taminiau, I. Danese, P. Denoel, A. Tibor, V. Weynants, A. Cloeckaert, J. Godfroid, and J.-J. Letesson. 1998. Identification of the perosamine synthetase gene of Brucella melitensis 16M and involvement of lipopolysaccharide O side chain in Brucella survival in mice and in macrophages. Infect. Immun. 66:5485-5493.
19. Jimenez de Bagues, M. P., P. H. Elzer, S. M. Jones, J. M. Blasco, F. M. Enright, G. G. Schurig, and A. J. Winter. 1994 Vaccination with Brucella abortus rough mutant RB51 protects BALB/c mice against virulent strains of Brucella abortus, Brucella melitensis, and Brucella ovis. Infect. Immun. 62: 4990-4996.
20. Jensen, A. E., D. R. Ewalt, N. F. Cheville, C. O. Thoen, and J. B. Payeur. 1996. Determination of stability of Brucella abortus RB51 by use of genomic fingerprint, oxidative metabolism, and colonial morphology and differentiation of strain RB51 from B. abortus isolates from bison and elk. J. Clin. Microbiol. 34:628-633.
21. Kovach, M. E., R. W. Phillips, P. H. Elzer, R. M. Roop, and K. M. Peterson. 1994. pBBR1MCS: a broad-host-range cloning vector. BioTechniques 16: 800-801.
22. Lord, V. R., G. G. Schurig, J. W. Cherwonogrodzky, M. J. Marcano, and G. E. Melendez. 1998. Field study of vaccination of cattle with Brucella abortus strains RB51 and 19 under high and low disease prevalence. Am. J. Vet. Res. 59:1016-1020.
23. Martinez de Tejada, G., J. Pizarro-Cerda, E. Moreno, and I. Moriyon. 1995. The outer membranes of Brucella spp. are resistant to bactericidal cationic peptides. Infect. Immun. 63:3054-3061.
24. McQuiston, J. R., G. G. Schurig, N. Sriranganathan, and S. M. Boyle. 1995. Transformation of Brucella species with suicide and broad host-range plasmids. Methods Mol. Biol. 47:143-148.
25. Mcquiston, J. R., R. Vemulapalli, T. J. Inzana, G. G. Schurig, N. Sriranganathan, D. Fritzinger, T. L. Hadfield, R. A. Warren, N. Snellings, D. Hoover, S. M. Halling, and S. M. Boyle. 1999. Genetic characterization of a Tn5-disrupted glycosyltransferase gene homolog in Brucella abortus and its effect on lipopolysaccharide composition and virulence. Infect. Immun. 67:3830-3835.
26. Montaraz, J. A., A. J. Winter, D. M. Hunter, B. A. Sowa, A. M. Wu, and L. G. Adams. 1986. Protection against Brucella abortus in mice with O-polysaccharide-specific monoclonal antibodies. Infect. Immun. 51:961-963.
27. Palmer, M. V., S. C. Olsen, and N. F. Cheville. 1997. Safety and immunogenicity of Brucella abortus strain RB51 vaccine in pregnant cattle. Am. J. Vet. Res. 58:472-477.
28. Pizarro-Cerda, J., E. Moreno, V. Sanguedolce, J.-L. Mege, and J.-P. Gorvel. 1998. Virulent Brucella abortus avoids lysosome fusion and distributes within autophagosome-like compartments. Infect. Immun. 66:2387-2392.
29. Roop, R. M., D. Preston-Moore, T. Bagchi, and G. G. Schurig. 1987. Rapid identification of smooth Brucella species with a monoclonal antibody. J. Clin. Microbiol. 25:2090-2093.
30. Samartino, L. E., and F. M. Enright. 1993. Pathogenesis of abortion of bovine brucellosis. Comp. Immunol. Microbiol. Infect. Dis. 16:95-101.
31. Schurig, G. G., C. Hammerberg, and B. Finkler. 1984. Monoclonal antibodies to Brucella surface antigens associated with smooth lipopolysaccharide complex. Am. J. Vet. Res. 45:967-971.
32. Schurig, G. G., R. M. Roop II, T. Bagchi, S. Boyle, D. Buhrman, and N. Sriranganathan. 1991. Biological properties of RB51; a stable rough strain of Brucella abortus. Vet. Microbiol. 28:171-188.
33. Stevens, T. L., A. Bossie, V. M. Sanders, R. Fernandez-Botran, R. L. Coffman, T. R. Mosmann, and E. S. Vitetta. 1988. Regulation of antibody isotype secretion by subsets of antigen-specific helper T cells. Nature 334:255-258.
34. Vemulapalli, R., A. J. Duncan, S. M. Boyle, N. Sriranganathan, T. E. Toth, and G. G. Schurig. 1998. Cloning and sequencing of yajC and secD homologs of Brucella abortus and demonstration of immune responses to YajC in mice vaccinated with B. abortus RB51. Infect. Immun. 66:5684-5691.
35. Vemulapalli, R., J. R. McQuiston, G. G. Schurig, N. Sriranganathan, S. M. Halling, and S. M. Boyle. 1999. Identification of an IS711 element interrupting the wboA gene of Brucella abortus vaccine strain RB51 and a PCR assay to distinguish strain RB51 from other Brucella species and strains. Clin. Diagn. Lab. Immunol. 6:760-764.
36. White, P. G., and J. B. Wilson. 1951. Differentiation of smooth and non-smooth colonies of brucellae. J. Bacteriol. 61:239-240.
37. Winter, A. J., G. G. Schurig, S. M. Boyle, N. Sriranganathan, J. S. Bevins, F. M. Enright, P. H. Elzer, and J. D. Kopec. 1996. Protection of BALB/c mice against homologous and heterologous species of Brucella by rough strain vaccines derived from Brucella melitensis and Brucella suis biovar 4. Am. J. Vet. Res. 57:677-683.